Maternal serum heme-oxygenase-1 (HO-1) concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus.

<h4>Background</h4>Heme oxygenase-1 (HO-1) concentrations have been recently reported to be elevated in impaired glucose tolerance and type 2 diabetes mellitus (T2DM). However, no study has examined the association between HO-1 concentrations and gestational diabetes mellitus (GDM).<h...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chunfang Qiu, Karin Hevner, Daniel A Enquobahrie, Michelle A Williams
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/d804df60ac574272be047c84e932d938
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d804df60ac574272be047c84e932d938
record_format dspace
spelling oai:doaj.org-article:d804df60ac574272be047c84e932d9382021-11-18T08:09:58ZMaternal serum heme-oxygenase-1 (HO-1) concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus.1932-620310.1371/journal.pone.0048060https://doaj.org/article/d804df60ac574272be047c84e932d9382012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23139759/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Heme oxygenase-1 (HO-1) concentrations have been recently reported to be elevated in impaired glucose tolerance and type 2 diabetes mellitus (T2DM). However, no study has examined the association between HO-1 concentrations and gestational diabetes mellitus (GDM).<h4>Methods</h4>In a case-control study, nested within a prospective cohort of pregnant women (186 GDM cases and 191 women who remained eu-glycemic through pregnancy), we assessed the association of maternal serum HO-1 concentrations, measured in samples collected at 16 weeks gestation, on average, with subsequent risk of GDM. Maternal serum HO-1 concentrations were determined using ELISA. We fitted multivariate logistic regression models to derive estimates of odds ratios (ORs) and 95% confidence intervals (CIs).<h4>Results</h4>Median serum HO-1 concentrations in early pregnancy were lower in women who subsequently developed GDM compared with those who did not (1.60 vs. 1.80 ng/mL, p-value=0.002). After adjusting for maternal age, race, family history of T2DM and pre-pregnancy body mass index, women with HO-1 ≥ 3.05 ng/mL (highest decile) experienced a 74% reduction of GDM risk (95% CI; 0.09-0.77) compared with women whose concentrations were<1.23 ng/mL (lowest quartile).<h4>Conclusion</h4>Serum HO-1 concentrations were inversely associated with subsequent GDM risk. These findings underscore the role of oxidative stress in the pathogenesis of GDM. Additional studies are warranted to confirm the clinical utility of serum HO-1 in diagnosis of GDM, particularly in the early pregnancy.Chunfang QiuKarin HevnerDaniel A EnquobahrieMichelle A WilliamsPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 11, p e48060 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Chunfang Qiu
Karin Hevner
Daniel A Enquobahrie
Michelle A Williams
Maternal serum heme-oxygenase-1 (HO-1) concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus.
description <h4>Background</h4>Heme oxygenase-1 (HO-1) concentrations have been recently reported to be elevated in impaired glucose tolerance and type 2 diabetes mellitus (T2DM). However, no study has examined the association between HO-1 concentrations and gestational diabetes mellitus (GDM).<h4>Methods</h4>In a case-control study, nested within a prospective cohort of pregnant women (186 GDM cases and 191 women who remained eu-glycemic through pregnancy), we assessed the association of maternal serum HO-1 concentrations, measured in samples collected at 16 weeks gestation, on average, with subsequent risk of GDM. Maternal serum HO-1 concentrations were determined using ELISA. We fitted multivariate logistic regression models to derive estimates of odds ratios (ORs) and 95% confidence intervals (CIs).<h4>Results</h4>Median serum HO-1 concentrations in early pregnancy were lower in women who subsequently developed GDM compared with those who did not (1.60 vs. 1.80 ng/mL, p-value=0.002). After adjusting for maternal age, race, family history of T2DM and pre-pregnancy body mass index, women with HO-1 ≥ 3.05 ng/mL (highest decile) experienced a 74% reduction of GDM risk (95% CI; 0.09-0.77) compared with women whose concentrations were<1.23 ng/mL (lowest quartile).<h4>Conclusion</h4>Serum HO-1 concentrations were inversely associated with subsequent GDM risk. These findings underscore the role of oxidative stress in the pathogenesis of GDM. Additional studies are warranted to confirm the clinical utility of serum HO-1 in diagnosis of GDM, particularly in the early pregnancy.
format article
author Chunfang Qiu
Karin Hevner
Daniel A Enquobahrie
Michelle A Williams
author_facet Chunfang Qiu
Karin Hevner
Daniel A Enquobahrie
Michelle A Williams
author_sort Chunfang Qiu
title Maternal serum heme-oxygenase-1 (HO-1) concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus.
title_short Maternal serum heme-oxygenase-1 (HO-1) concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus.
title_full Maternal serum heme-oxygenase-1 (HO-1) concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus.
title_fullStr Maternal serum heme-oxygenase-1 (HO-1) concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus.
title_full_unstemmed Maternal serum heme-oxygenase-1 (HO-1) concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus.
title_sort maternal serum heme-oxygenase-1 (ho-1) concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/d804df60ac574272be047c84e932d938
work_keys_str_mv AT chunfangqiu maternalserumhemeoxygenase1ho1concentrationsinearlypregnancyandsubsequentriskofgestationaldiabetesmellitus
AT karinhevner maternalserumhemeoxygenase1ho1concentrationsinearlypregnancyandsubsequentriskofgestationaldiabetesmellitus
AT danielaenquobahrie maternalserumhemeoxygenase1ho1concentrationsinearlypregnancyandsubsequentriskofgestationaldiabetesmellitus
AT michelleawilliams maternalserumhemeoxygenase1ho1concentrationsinearlypregnancyandsubsequentriskofgestationaldiabetesmellitus
_version_ 1718422138245873664